Sex-specific remodeling of the tRNA epitranscriptome in Alzheimers disease
Marko JörgiD, Lukas Walz, Marc LanderiD, Larissa Bessler, Sebastian Nathal, Kristine FreudeiD, Kristina EndresiD, Mark HelmiD, Kristina FriedlandiD
Abstract
tRNA modifications are critical regulators of RNA stability, decoding fidelity, and cellular stress adaptation, yet their contribution to human neurodegenerative disease remains poorly understood. Beyond their established functions in translational control, emerging evidence shows that RNA modifications influence neurogenesis, neurodevelopment, neuronal function, brain-cell differentiation, and cellular plasticity. Consequently, dysregulation of these molecular processes is increasingly recognized as a mechanistic contributor to neurodegenerative disorders. Alzheimers disease (AD), characterized by amyloid pathology, synaptic dysfunction, and progressive neuronal loss, has recently been linked to disturbances in RNA metabolism, suggesting that alterations in the epitranscriptome may represent an underexplored dimension of AD pathophysiology. Here, we systematically profiled the tRNA epitranscriptome across cellular and animal models of AD, as well as in human postmortem brain tissue from non-demented controls and AD patients, using liquid chromatography-tandem mass spectrometry (LC-MS/MS). This method enables highly sensitive quantification of RNA modifications, with limits of detection in the low femtomole range. Across our models, we identified a conserved yet sex-specific remodeling of the tRNA modification landscape in AD. Because therapeutic options and early diagnostic tools for AD remain limited, we leveraged these findings to develop a tRNA-centered RNA-modification score that integrates both nucleobase-specific modification patterns and neuropathological disease severity into a quantitative metric. Together, our findings identify the tRNA epitranscriptome as a unifying molecular sex-specific signature of AD, linking disease pathology and sex to impaired RNA metabolism. This line of research opens a new path toward establishing early biomarkers or diagnostic tools for AD. Graphical abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=77 SRC="FIGDIR/small/715648v1_ufig1.gif" ALT="Figure 1"> View larger version (25K): org.highwire.dtl.DTLVardef@174c203org.highwire.dtl.DTLVardef@6d610aorg.highwire.dtl.DTLVardef@fddeecorg.highwire.dtl.DTLVardef@136700e_HPS_FORMAT_FIGEXP M_FIG C_FIG
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- RNA-seq variants reveal distinct patterns in the aging epitranscriptome: an in-depth analysis of age-matched Alzheimer's Disease patients and a cognitively normal cohort
Katherine A. Jensen, Jennifer W Weller, Kristen E. Funk·bioRxiv·Feb 16, 2026
- Small RNA modifications in Alzheimers disease
X. Zhang, F. Trebak, … Y. Feng Earley·Neurobiology of DiseasePeer-reviewed·Nov 1, 2020
- Amyloid pathology reduces ELP3 expression and tRNA modifications leading to impaired proteostasis in Alzheimer's disease models
Marisa Pereira, Diana Roberta Ribeiro, … Ana Raquel Soares·bioRxiv·May 2, 2023
- Sex-specific declines in cholinergic-targeting tRNA fragments in the nucleus accumbens in Alzheimer's disease
Dana Shulman, Serafima Dubnov, … Hermona Soreq·Alzheimer s & DementiaPeer-reviewed·May 9, 2023
- Methylomic signatures of tau and amyloid-beta in transgenic mouse models of Alzheimer's disease neuropathology
Szi Kay Leung, Emma Walker, … Jonathan S. Mill·npj DementiaPeer-reviewed·Apr 7, 2026
- Identification and Analysis of Novel RNA Editing Sites in Neurodegenerative Diseases Using Machine Learning Approaches.
Shabistan Jabin, Elamathi Natarajan·bioRxiv·Apr 13, 2026